Unicycive Therapeutics (UNCY) Accounts Payables (2020 - 2026)
Unicycive Therapeutics (UNCY) posted Accounts Payables of $2.23 million for Q2 2026, up 188.3% from $775,000 a year earlier and up 96.0% from the prior quarter.
Unicycive Therapeutics (UNCY) Accounts Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, Unicycive Therapeutics' Accounts Payables came in at $383,000, down 63.8% from FY2024.
- Annual Accounts Payables shows a five-year compound annual growth rate of 15.8% (FY2020 to FY2025).
- In prior years, Unicycive Therapeutics' Accounts Payables was $1.06 million in FY2024 (-47.1%), $2 million in FY2023 (+124.2%), $892,000 in FY2022 (+20.2%) and $742,000 in FY2021 (+303.3%).
- The Q2 2026 figure stands as the highest quarterly Accounts Payables since Q3 2022.
- On a year-over-year basis, Accounts Payables increased in three of the last eight quarters, with growth averaging 6.2%.
- The strongest year-over-year quarter for Accounts Payables in the past five years was Q4 2021, with growth of 303.3%; the weakest was Q4 2025, with a decline of 63.8%.
- According to Business Quant data, Accounts Payables for the three prior quarters was $1.14 million (Q1 2026), $383,000 (Q4 2025) and $957,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Unicycive Therapeutics | 104.17 Mn | -95.81 Mn | - | 2.23 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.23 Mn |
| Mar 31, 2026 | 1.14 Mn |
| Dec 31, 2025 | 383,000.00 |
| Sep 30, 2025 | 957,000.00 |
| Jun 30, 2025 | 775,000.00 |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | 548,000.00 |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 1.24 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Sep 30, 2023 | 1.08 Mn |
| Jun 30, 2023 | 503,000.00 |
| Mar 31, 2023 | 790,000.00 |
| Dec 31, 2022 | 892,000.00 |
| Sep 30, 2022 | 2.29 Mn |
| Jun 30, 2022 | 747,000.00 |
| Mar 31, 2022 | 589,000.00 |
| Dec 31, 2021 | 742,000.00 |
| Sep 30, 2021 | 49,000.00 |
Unicycive Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=UNCY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "UNCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=UNCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();